Master10
General Science20 Concepts & Facts

Organ Transplant Matching GK Facts, HLA Antigens & Graft Compatibility Guide

Reviewed by the Master10 Editorial Board for accuracy, clarity and competitive-exam relevance.Editorial Policy
Organ transplantation is the surgical procedure in which a failing organ is replaced with a functioning graft from a donor, providing life-saving interventions for end-stage heart, kidney, liver, or lung disease. Most clinical transplants involve an allograft, where tissue is transferred between genetically distinct members of the same species. Ever since Joseph Murray performed the first successful human kidney transplant between identical twins in 1954, medical researchers recognized that genetic disparity between unrelated individuals triggers vigorous immune responses. Because human immune systems evolved to eliminate foreign biological invaders, the recipient's immune cells inevitably identify foreign donor cell-surface proteins as non-self threats. Without precise immunological matching and post-transplant medical management, recipient lymphocytes launch an aggressive attack that destroys the graft, causing acute organ failure.

Transplant matching begins with mandatory ABO blood group testing to prevent immediate hemolytic destruction, followed by comprehensive Human Leukocyte Antigen typing. Encoded by the Major Histocompatibility Complex genes located on chromosome 6, HLA glycoproteins present peptide fragments to circulating T cells. Clinical matching focuses heavily on six key polymorphic loci: HLA-A, HLA-B, and HLA-DR. Prior to surgery, crossmatching tests recipient serum against donor lymphocytes using Complement-Dependent Cytotoxicity assays or flow cytometry to evaluate panel reactive antibodies. A positive crossmatch indicates that the recipient harbors pre-existing donor-specific antibodies, which would trigger catastrophic hyperacute rejection within minutes of blood vessel connection. Later rejections include acute cellular rejection mediated by cytotoxic T cells weeks after surgery and chronic rejection characterized by progressive vascular thickening and fibrosis over years.

To prevent graft destruction, transplant recipients require lifelong immunosuppressive therapy using medications like calcineurin inhibitors (cyclosporine and tacrolimus) and antimetabolites that silence lymphocyte activation. In India, the ethical governance and legal regulation of organ donation falls under the Transplantation of Human Organs and Tissues Act of 1994, which legally defined brain stem death and banned commercial trade in human organs. Deceased donor allocations are coordinated across regional networks by the National Organ and Tissue Transplant Organization under the Ministry of Health and Family Welfare. In competitive examinations, questions frequently focus on HLA inheritance, the mechanisms of hyperacute versus acute rejection, immunosuppressive drug actions, and the statutory rules governing living and cadaveric donations under Indian law.

Key Concepts & Self-Assessment20 Key Facts

Review key Organ Transplant Matching: HLA Typing, Crossmatching & Immunological Compatibility exam facts and rate your mastery to track revision.

Progress: 0/20 Rated 0 Mastered 0 Review Later
#1
An allograft is an organ or tissue transplanted between genetically non-identical individuals of the same species, representing the most common clinical transplant type.
#2
An autograft involves tissue transferred within the same individual, an isograft occurs between identical twins, and a xenograft involves transplantation between different biological species.
#3
ABO blood group compatibility is a mandatory baseline prerequisite for organ transplantation to prevent immediate isohemagglutinin-mediated graft damage.
#4
Human Leukocyte Antigens (HLA) are cell-surface glycoproteins encoded by the Major Histocompatibility Complex (MHC) gene cluster located on the short arm of chromosome 6.
#5
HLA Class I antigens (HLA-A, HLA-B, HLA-C) are expressed on all nucleated cells and platelets, presenting endogenous peptides to CD8+ cytotoxic T cells.
#6
HLA Class II antigens (HLA-DR, HLA-DP, HLA-DQ) are expressed on professional antigen-presenting cells (dendritic cells, macrophages, B cells), presenting exogenous peptides to CD4+ helper T cells.
#7
Standard clinical kidney transplant matching evaluates six antigen loci (two HLA-A, two HLA-B, and two HLA-DR), where a zero-mismatch (6/6 match) yields superior long-term graft survival.
#8
A pre-transplant crossmatch mixes recipient serum with donor lymphocytes to check for preformed donor-specific antibodies (DSAs).
#9
Complement-Dependent Cytotoxicity (CDC) crossmatching is the historical gold standard; a positive CDC crossmatch is an absolute contraindication to transplantation.
#10
Panel Reactive Antibody (PRA) or Calculated PRA (cPRA) tests measure the percentage of potential donor population cells that react with a patient's serum, assessing recipient sensitization from prior blood transfusions, pregnancies, or previous transplants.
#11
Hyperacute rejection occurs within minutes to hours after vascular anastomosis, caused by pre-existing circulating antibodies binding to donor graft endothelial antigens, triggering complement activation, thrombosis, and ischemic necrosis.
#12
Acute allograft rejection typically occurs within weeks to months post-transplant, primarily driven by recipient T cells recognizing foreign HLA molecules (cellular rejection) or de novo donor-specific antibodies (antibody-mediated rejection).
#13
Chronic allograft rejection develops over months to years, characterized by gradual graft arteriosclerosis, interstitial fibrosis, tubular atrophy, and progressive organ failure.
#14
Calcineurin inhibitors, specifically cyclosporine and tacrolimus, form the backbone of maintenance immunosuppression by blocking the calcineurin enzyme, preventing interleukin-2 (IL-2) transcription in T cells.
#15
Mycophenolate mofetil and azathioprine act as antimetabolite immunosuppressants by inhibiting purine synthesis, thereby arresting lymphocyte proliferation.
#16
In India, the legal foundation for organ harvesting and transplantation is the Transplantation of Human Organs Act (THOTA), enacted in 1994 and amended in 2011 to include human tissues.
#17
THOTA 1994 formally introduced the legal definition of brain stem death in India, enabling deceased (cadaveric) multi-organ procurement.
#18
The National Organ and Tissue Transplant Organization (NOTTO), based in New Delhi under the Ministry of Health and Family Welfare, coordinates nationwide deceased donor organ sharing and registry maintenance.
#19
Commercial trading, buying, or selling of human organs is a punishable criminal offense under THOTA, carrying strict imprisonment terms and heavy monetary fines.
#20
Living donor transplants under Indian law are permitted between near relatives (spouse, parents, siblings, children, grandparents, grandchildren); non-near relatives require mandatory scrutiny and clearance by a state-level Authorization Committee.

Subject Specialist Commentary

Analytical perspective & practical exam advice from the Master10 academic board

Educator's Insight
Organ transplant matching is the immunological process that ensures a donor organ safely survives inside a recipient's body. Because the human immune system attacks foreign cells, doctors must match biological markers between donor and patient. Testing begins with ABO blood groups, followed by Human Leukocyte Antigen typing on chromosome six. When markers closely align, the patient's immune system is far less likely to reject the new organ, allowing modern immunosuppressive medicines to maintain long-term organ health.
In UPSC and State PSC exams, examiners test transplant rejection timelines and Indian legal regulations. Remember the rejection sequence: hyperacute occurs within minutes due to preformed antibodies, acute takes weeks through T-cell attacks, and chronic develops over years through fibrosis. A classic question trap involves Indian law: the Transplantation of Human Organs Act was passed in 1994, legally defining brain stem death. Note that NOTTO coordinates national organ sharing, while living donations between non-relatives require government Authorization Committee approval.

Related Knowledge Topics to Discover

Looking for more GK practice?

Explore 52,789+ questions across 65 General Knowledge categories.

Open Interactive Search